STA Pharmaceutical to open new transition metal catalysis center
The center will allow STA to introduce transition metal catalyst-screening technology to their existing small molecule process development and manufacturing platform.
STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China. The new state-of-the-art facility will allow STA to carry out rapid screening of metal catalysts, ligands, bases, acids, chemical resolving reagents, and amide formation coupling reagents, etc. The screening kits will enable high-throughput screening of metal catalysts and ligands for C-C, C-N, C-O and C-S formation reactions, as well as many other types of reactions such as chemical resolution and amide formation. The technology allows the STA team to more rapidly find the optimal catalysts using a parallel interactive testing approach.
A team of scientists specialized in this technology are currently being trained in the company’s Shanghai R&D center, and, once the new center becomes fully operational in early November, will move to the Changzhou site.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Tierra Biosciences Launches First-Ever Online Protein Ordering Platform for Synthetic Biology Protein Engineering - Sourcing thousands of proteins for research and development
Analytica presents biotechnology highlights

When is the best time of day for cancer treatment? - Researchers are developing new methods to use the internal clock inside tumor cells to optimize cancer therapies

GSG GENII Software Group GmbH - München, Germany
PCA3 Test May Help Distinguish Aggressive Prostate Cancer - The PCA3 Test May Help Distinguish Between Benign and Aggressive
Congenital_heart_disease

Analytik Jena Science Award Honors Outstanding Scientific Articles
MedGenome secures series C funding

Genomics & Analytical Services | Analytical services | Azenta

Start-up dedicated to developing new antibiotics - Smartbax nominated for Falling Walls award
Biovitrum Makes the First Move to Focus on Specialist Care Diseases - Initiates the Process to Find Partners for Its Early Stage Primary Care Projects
